Difficulty: Medium
Average Score: 69%
Practice
All of these drugs are antiplatelet agents EXCEPT:
Correct answer
B
Rationale
In the context of safety pharmacology across the lifespan, understanding the mechanisms and actions of antiplatelet agents is crucial for healthcare professionals. In this question, the correct answer is B) Urokinase, as it is not an antiplatelet agent. Urokinase is a thrombolytic agent that works by activating plasminogen to break down blood clots, rather than preventing platelet aggregation like antiplatelet drugs.
A) Aspirin is an antiplatelet agent that inhibits cyclooxygenase, thereby reducing the formation of thromboxane A2, a potent platelet aggregator.
C) Ticlopidine and D) Clopidogrel are both antiplatelet agents that work by inhibiting the ADP pathway, thereby preventing platelet activation and aggregation.
Educationally, this question highlights the importance of differentiating between various classes of cardiovascular medications, especially antiplatelet agents, to ensure safe and effective pharmacological management. Understanding the mechanisms of action of these drugs is essential in tailoring treatment plans for patients across different age groups and health conditions.
A) Aspirin is an antiplatelet agent that inhibits cyclooxygenase, thereby reducing the formation of thromboxane A2, a potent platelet aggregator.
C) Ticlopidine and D) Clopidogrel are both antiplatelet agents that work by inhibiting the ADP pathway, thereby preventing platelet activation and aggregation.
Educationally, this question highlights the importance of differentiating between various classes of cardiovascular medications, especially antiplatelet agents, to ensure safe and effective pharmacological management. Understanding the mechanisms of action of these drugs is essential in tailoring treatment plans for patients across different age groups and health conditions.